Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Nanodiamond-Mediated Delivery of a G9a Inhibitor for Hepatocellular Carcinoma Therapy.

Gu M, Toh TB, Hooi L, Lim JJ, Zhang X, Chow EK.

ACS Appl Mater Interfaces. 2019 Nov 26. doi: 10.1021/acsami.9b16323. [Epub ahead of print]

PMID:
31718136
2.

Protocol for the Study of Heart and Renal Protection-Extended Review: Additional 5-Year Follow-up of the Australian, New Zealand, and Malaysian SHARP Cohort.

Sukkar L, Talbot B, Jun M, Dempsey E, Walker R, Hooi L, Cass A, Jardine M, Gallagher M.

Can J Kidney Health Dis. 2019 Oct 14;6:2054358119879896. doi: 10.1177/2054358119879896. eCollection 2019.

3.

Cost utility analysis of end stage renal disease treatment in Ministry of Health dialysis centres, Malaysia: Hemodialysis versus continuous ambulatory peritoneal dialysis.

Surendra NK, Abdul Manaf MR, Hooi LS, Bavanandan S, Mohamad Nor FS, Firdaus Khan SS, Meng OL, Abdul Gafor AH.

PLoS One. 2019 Oct 23;14(10):e0218422. doi: 10.1371/journal.pone.0218422. eCollection 2019.

4.

Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.

Toh TB, Lim JJ, Hooi L, Rashid MBMA, Chow EK.

J Hepatol. 2019 Sep 18. pii: S0168-8278(19)30547-1. doi: 10.1016/j.jhep.2019.08.035. [Epub ahead of print]

PMID:
31541681
5.

New High-Throughput Screening Identifies Compounds That Reduce Viability Specifically in Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative Phosphorylation.

Tan JL, Li F, Yeo JZ, Yong KJ, Bassal MA, Ng GH, Lee MY, Leong CY, Tan HK, Wu CS, Liu BH, Chan TH, Tan ZH, Chan YS, Wang S, Lim ZH, Toh TB, Hooi L, Low KN, Ma S, Kong NR, Stein AJ, Wu Y, Thangavelu MT, Suzuki A, Periyasamy G, Asara JM, Dan YY, Bonney GK, Chow EK, Lu GD, Ng HH, Kanagasundaram Y, Ng SB, Tam WL, Tenen DG, Chai L.

Gastroenterology. 2019 Dec;157(6):1615-1629.e17. doi: 10.1053/j.gastro.2019.08.022. Epub 2019 Aug 22.

PMID:
31446059
6.

Identifying critically important vascular access outcomes for trials in haemodialysis: an international survey with patients, caregivers and health professionals.

Viecelli AK, Howell M, Tong A, Teixeira-Pinto A, O'Lone E, Ju A, Craig JC, Hooi LS, Lee T, Lok CE, Polkinghorne KR, Quinn RR, Vachharajani TJ, Vanholder R, Zuo L, Tordoir J, Pecoits-Filho R, Yuo T, Kopperschmidt P, Smith R, Irish AB, Mori TA, Pascoe EM, Johnson DW, Hawley CM.

Nephrol Dial Transplant. 2019 Aug 1. pii: gfz148. doi: 10.1093/ndt/gfz148. [Epub ahead of print]

PMID:
31369099
7.

Health related quality of life of dialysis patients in Malaysia: Haemodialysis versus continuous ambulatory peritoneal dialysis.

Surendra NK, Abdul Manaf MR, Hooi LS, Bavanandan S, Mohamad Nor FS, Shah Firdaus Khan S, Ong LM, Abdul Gafor AH.

BMC Nephrol. 2019 Apr 30;20(1):151. doi: 10.1186/s12882-019-1326-x.

8.

Dual-Targeting Dual-Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity.

Babak MV, Zhi Y, Czarny B, Toh TB, Hooi L, Chow EK, Ang WH, Gibson D, Pastorin G.

Angew Chem Int Ed Engl. 2019 Jun 11;58(24):8109-8114. doi: 10.1002/anie.201903112. Epub 2019 Apr 23.

PMID:
30945417
9.

Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial.

Viecelli AK, Polkinghorne KR, Pascoe EM, Paul-Brent PA, Hawley CM, Badve SV, Cass A, Hooi LS, Kerr PG, Mori TA, Ong LM, Voss D, Johnson DW, Irish AB; Omega-3 Fatty Acids (Fish Oils) and Aspirin in Vascular Access Outcomes in Renal Disease (FAVOURED) Study Collaborative Group.

PLoS One. 2019 Mar 26;14(3):e0213274. doi: 10.1371/journal.pone.0213274. eCollection 2019.

11.

The point-of-care Bilistick method has very short turn-around-time and high accuracy at lower cutoff levels to predict laboratory-measured TSB.

Boo NY, Chang YF, Leong YX, Tok ZY, Hooi LC, Chee SC, Latif ZA.

Pediatr Res. 2019 Aug;86(2):216-220. doi: 10.1038/s41390-019-0304-0. Epub 2019 Jan 23.

PMID:
30696987
12.

Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP).

Rashid MBMA, Toh TB, Hooi L, Silva A, Zhang Y, Tan PF, Teh AL, Karnani N, Jha S, Ho CM, Chng WJ, Ho D, Chow EK.

Sci Transl Med. 2018 Aug 8;10(453). pii: eaan0941. doi: 10.1126/scitranslmed.aan0941.

PMID:
30089632
13.

Nephrology in the Oceania-South East Asia region: perspectives and challenges.

Kerr PG, Tran HTB, Ha Phan HA, Liew A, Hooi LS, Johnson DW, Levin A; OSEA Regional Board.

Kidney Int. 2018 Sep;94(3):465-470. doi: 10.1016/j.kint.2018.05.014. Epub 2018 Jul 23. No abstract available.

PMID:
30045813
14.

Datasets describing the growth and molecular features of hepatocellular carcinoma patient-derived xenograft cells grown in a three-dimensional macroporous hydrogel.

Fong ELS, Toh TB, Lin QXX, Liu Z, Hooi L, Rashid MBMA, Benoukraf T, Chow EK, Huynh TH, Yu H.

Data Brief. 2018 Mar 17;18:594-606. doi: 10.1016/j.dib.2018.03.045. eCollection 2018 Jun.

15.

Glomerular Filtration Rates in Asians.

Teo BW, Zhang L, Guh JY, Tang SCW, Jha V, Kang DH, Tanchanco R, Hooi LS, Praditpornsilpa K, Kong X, Zuo L, Chan GC, Lee EJC.

Adv Chronic Kidney Dis. 2018 Jan;25(1):41-48. doi: 10.1053/j.ackd.2017.10.005. Review.

PMID:
29499886
16.

Report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop on Establishing a Core Outcome Measure for Hemodialysis Vascular Access.

Viecelli AK, Tong A, O'Lone E, Ju A, Hanson CS, Sautenet B, Craig JC, Manns B, Howell M, Chemla E, Hooi LS, Johnson DW, Lee T, Lok CE, Polkinghorne KR, Quinn RR, Vachharajani T, Vanholder R, Zuo L, Hawley CM; SONG-HD Vascular Access Workshop Investigators.

Am J Kidney Dis. 2018 May;71(5):690-700. doi: 10.1053/j.ajkd.2017.12.003. Epub 2018 Feb 23. Review.

PMID:
29478866
17.

Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer.

Fong ELS, Toh TB, Lin QXX, Liu Z, Hooi L, Mohd Abdul Rashid MB, Benoukraf T, Chow EK, Huynh TH, Yu H.

Biomaterials. 2018 Mar;159:229-240. doi: 10.1016/j.biomaterials.2017.12.026. Epub 2018 Jan 4.

PMID:
29353739
18.

Large intramural hematoma and gastric ulcer after EMR of a small gastric polyp.

Teh J, Krishnamoorthy TL, Hooi LC, Asokkumar R.

Gastrointest Endosc. 2018 Jun;87(6):1585-1586. doi: 10.1016/j.gie.2017.12.003. Epub 2017 Dec 6. No abstract available.

PMID:
29223380
19.

Vascular Access Outcomes Reported in Maintenance Hemodialysis Trials: A Systematic Review.

Viecelli AK, O'Lone E, Sautenet B, Craig JC, Tong A, Chemla E, Hooi LS, Lee T, Lok C, Polkinghorne KR, Quinn RR, Vachharajani T, Vanholder R, Zuo L, Irish AB, Mori TA, Pascoe EM, Johnson DW, Hawley CM.

Am J Kidney Dis. 2018 Mar;71(3):382-391. doi: 10.1053/j.ajkd.2017.09.018. Epub 2017 Dec 6.

PMID:
29203125
20.

Deep Brain Stimulation (DBS) for Movement Disorders: An Experience in Hospital Universiti Sains Malaysia (HUSM) Involving 12 Patients.

Hooi LL, Fitzrol DN, Rajapathy SK, Chin TY, Halim SA, Kandasamy R, Hassan WMNW, Idris B, Ghani ARI, Idris Z, Tharakan J, Nunta-Aree S, Abdullah JM.

Malays J Med Sci. 2017 Mar;24(2):87-93. doi: 10.21315/mjms2017.24.2.11. Epub 2017 Apr 14.

21.

Acute Kidney Injury Risk Assessment: Differences and Similarities Between Resource-Limited and Resource-Rich Countries.

Kashani K, Macedo E, Burdmann EA, Hooi LS, Khullar D, Bagga A, Chakravarthi R, Mehta R.

Kidney Int Rep. 2017 Jul;2(4):519-529. doi: 10.1016/j.ekir.2017.03.014. Epub 2017 Apr 25.

22.

Effect of Fish Oil Supplementation and Aspirin Use on Arteriovenous Fistula Failure in Patients Requiring Hemodialysis: A Randomized Clinical Trial.

Irish AB, Viecelli AK, Hawley CM, Hooi LS, Pascoe EM, Paul-Brent PA, Badve SV, Mori TA, Cass A, Kerr PG, Voss D, Ong LM, Polkinghorne KR; Omega-3 Fatty Acids (Fish Oils) and Aspirin in Vascular Access Outcomes in Renal Disease (FAVOURED) Study Collaborative Group.

JAMA Intern Med. 2017 Feb 1;177(2):184-193. doi: 10.1001/jamainternmed.2016.8029.

23.

Preclinical Characterization and Human Microdose Pharmacokinetics of ITMN-8187, a Nonmacrocyclic Inhibitor of the Hepatitis C Virus NS3 Protease.

Rajagopalan R, Pan L, Schaefer C, Nicholas J, Lim S, Misialek S, Stevens S, Hooi L, Aleskovski N, Ruhrmund D, Kossen K, Huang L, Yap S, Beigelman L, Serebryany V, Liu J, Sastry S, Seiwert S, Buckman B.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e01569-16. doi: 10.1128/AAC.01569-16. Print 2017 Jan.

24.

Updates on baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study.

Viecelli AK, Pascoe EM, Polkinghorne KR, Hawley CM, Paul-Brent PA, Badve SV, Cass A, Johnson DW, Kerr PG, Mori TA, Scaria A, Hooi LS, Ong LM, Irish AB; FAVOURED study team.

Nephrology (Carlton). 2017 Oct;22(10):823-824. doi: 10.1111/nep.12823. No abstract available.

PMID:
27188542
25.

Risk of Peritoneal Dialysis-Related Peritonitis in a Multi-Racial Asian Population.

Ong LM, Ch'ng CC, Wee HC, Supramaniam P, Zainal H, Goh BL, Bavanandan S, Mushahar L, Hooi LS, Ahmad G.

Perit Dial Int. 2017 1-2;37(1):35-43. doi: 10.3747/pdi.2015.00141. Epub 2016 May 4.

PMID:
27147287
26.

The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection.

Herrington W, Emberson J, Staplin N, Blackwell L, Fellström B, Walker R, Levin A, Hooi LS, Massy ZA, Tesar V, Reith C, Haynes R, Baigent C, Landray MJ; SHARP Investigators.

Clin J Am Soc Nephrol. 2014 May;9(5):914-9. doi: 10.2215/CJN.10371013. Epub 2014 Mar 13.

27.

A population-based study measuring the prevalence of chronic kidney disease among adults in West Malaysia.

Hooi LS, Ong LM, Ahmad G, Bavanandan S, Ahmad NA, Naidu BM, Mohamud WN, Yusoff MF.

Kidney Int. 2013 Nov;84(5):1034-40. doi: 10.1038/ki.2013.220. Epub 2013 Jun 12.

28.

Lupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice?

Rovin BH, Parikh SV, Hebert LA, Chan TM, Mok CC, Ginzler EM, Hooi LS, Brunetta P, Maciuca R, Solomons N.

Clin J Am Soc Nephrol. 2013 Jan;8(1):147-53. doi: 10.2215/CJN.03290412. Epub 2012 Aug 9. Review.

29.

Virologic escape during danoprevir (ITMN-191/RG7227) monotherapy is hepatitis C virus subtype dependent and associated with R155K substitution.

Lim SR, Qin X, Susser S, Nicholas JB, Lange C, Herrmann E, Hong J, Arfsten A, Hooi L, Bradford W, Nájera I, Smith P, Zeuzem S, Kossen K, Sarrazin C, Seiwert SD.

Antimicrob Agents Chemother. 2012 Jan;56(1):271-9. doi: 10.1128/AAC.05636-11. Epub 2011 Nov 7.

30.

Asian chronic kidney disease best practice recommendations: positional statements for early detection of chronic kidney disease from Asian Forum for Chronic Kidney Disease Initiatives (AFCKDI).

Li PK, Chow KM, Matsuo S, Yang CW, Jha V, Becker G, Chen N, Sharma SK, Chittinandana A, Chowdhury S, Harris DC, Hooi LS, Imai E, Kim S, Kim SG, Langham R, Padilla BS, Teo BW, Togtokh A, Walker RG, Wang HY, Tsukamoto Y; Asian Forum for Chronic Kidney Disease Initiatives.

Nephrology (Carlton). 2011 Sep;16(7):633-41. doi: 10.1111/j.1440-1797.2011.01503.x. No abstract available.

PMID:
21771177
31.

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators.

Lancet. 2011 Jun 25;377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3. Epub 2011 Jun 12.

32.

Schizophrenia in Malaysian families: A study on factors associated with quality of life of primary family caregivers.

ZamZam R, Midin M, Hooi LS, Yi EJ, Ahmad SN, Azman SF, Borhanudin MS, Radzi RS.

Int J Ment Health Syst. 2011 Jun 8;5(1):16. doi: 10.1186/1752-4458-5-16.

33.

Increasing home-based dialysis therapies to tackle dialysis burden around the world: A position statement on dialysis economics from the 2nd Congress of the International Society for Hemodialysis.

Li PK, Cheung WL, Lui SL, Blagg C, Cass A, Hooi LS, Lee HY, Locatelli F, Wang T, Yang CW, Canaud B, Cheng YL, Choong HL, Francisco AL, Gura V, Kaizu K, Kerr PG, Kuok UI, Leung CB, Lo WK, Misra M, Szeto CC, Tong KL, Tungsanga K, Walker R, Wong AK, Yu AW; Roundtable Discussion on Dialysis Economics in the 2nd Congress of the International Society for Hemodialysis, Hong Kong, August 2009.

Hemodial Int. 2011 Jan;15(1):10-4. doi: 10.1111/j.1542-4758.2010.00512.x. Epub 2011 Jan 14. No abstract available.

PMID:
21231996
34.

Increasing home based dialysis therapies to tackle dialysis burden around the world: a position statement on dialysis economics from the 2nd Congress of the International Society for Hemodialysis.

Li PK, Cheung WL, Lui SL, Blagg C, Cass A, Hooi LS, Lee HY, Locatelli F, Wang T, Yang CW, Canaud B, Cheng YL, Choong HL, de Francisco AL, Gura V, Kaizu K, Kerr PG, Kuok UI, Leung CB, Lo WK, Misra M, Szeto CC, Tong KL, Tungsanga K, Walker R, Wong AK, Yu AW; Roundtable Discussion on Dialysis Economics in the Second Congress of the International Society for Hemodialysis (ISHD 2009).

Nephrology (Carlton). 2011 Jan;16(1):53-6. doi: 10.1111/j.1440-1797.2010.01418.x. No abstract available.

PMID:
21175978
35.

Complications after tenckhoff catheter insertion: a single-centre experience using multiple operators over four years.

Liu WJ, Hooi LS.

Perit Dial Int. 2010 Sep-Oct;30(5):509-12. doi: 10.3747/pdi.2009.00083. Epub 2010 Mar 12. Erratum in: Perit Dial Int. 2010 Nov-Dec;30(6):592.

PMID:
20228175
36.

HCV NS5B polymerase inhibitors 1: Synthesis and in vitro activity of 2-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-1-hydroxynaphthalene derivatives.

Wang G, He Y, Sun J, Das D, Hu M, Huang J, Ruhrmund D, Hooi L, Misialek S, Ravi Rajagopalan PT, Stoycheva A, Buckman BO, Kossen K, Seiwert SD, Beigelman L.

Bioorg Med Chem Lett. 2009 Aug 1;19(15):4476-9. doi: 10.1016/j.bmcl.2009.05.063. Epub 2009 May 23.

PMID:
19502055
37.

HCV NS5B polymerase inhibitors 2: Synthesis and in vitro activity of (1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl) azolo[1,5-a]pyridine and azolo[1,5-a]pyrimidine derivatives.

Wang G, Lei H, Wang X, Das D, Hong J, Mackinnon CH, Coulter TS, Montalbetti CA, Mears R, Gai X, Bailey SE, Ruhrmund D, Hooi L, Misialek S, Rajagopalan PT, Cheng RK, Barker JJ, Felicetti B, Schönfeld DL, Stoycheva A, Buckman BO, Kossen K, Seiwert SD, Beigelman L.

Bioorg Med Chem Lett. 2009 Aug 1;19(15):4480-3. doi: 10.1016/j.bmcl.2009.05.022. Epub 2009 May 9.

PMID:
19500983
38.

HCV NS5B polymerase inhibitors 3: Synthesis and in vitro activity of 3-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-4-hydroxy-2H-quinolizin-2-one derivatives.

Wang G, Zhang L, Wu X, Das D, Ruhrmund D, Hooi L, Misialek S, Ravi Rajagopalan PT, Buckman BO, Kossen K, Seiwert SD, Beigelman L.

Bioorg Med Chem Lett. 2009 Aug 1;19(15):4484-7. doi: 10.1016/j.bmcl.2009.05.021. Epub 2009 May 9.

PMID:
19497737
39.

National Transplant Registry.

Hooi LS, Lela Yasmin M.

Med J Malaysia. 2008 Sep;63 Suppl C:9-12. No abstract available.

PMID:
19230241
40.
41.

A randomized, multicenter, open-label trial to establish therapeutic equivalence between the Carex and ultra disconnect systems in patients on continuous ambulatory peritoneal dialysis.

Ong LM, Lim TO, Hooi LS, Morad Z, Tan PC, Wong HS, Lim YN, Ghazalli R, Tan CC, Shaariah W, Liew BS.

Perit Dial Int. 2003 Dec;23 Suppl 2:S139-43.

PMID:
17986534
42.

Increased utilization of peritoneal dialysis to cope with mounting demand for renal replacement therapy--perspectives from Asian countries.

Li PK, Lui SL, Leung CB, Yu AW, Lee E, Just PM, Abraham G, Almazan-Gomez L, Huang CC, Hooi LS, Kawaguchi Y, Kuok UI, Tungsanga K, Wang T, Wong AK, Yu XQ, Lo WK; Participants of the Roundtable Discussion on Dialysis Economics in Asia.

Perit Dial Int. 2007 Jun;27 Suppl 2:S59-61.

PMID:
17556331
43.

Lactic acidosis in HIV patients receiving highly active antiretroviral therapy.

Chow YW, Leong CL, Chow HL, Hooi LS.

Med J Malaysia. 2007 Mar;62(1):78-80.

44.

Acute renal failure in the same hospital ten years apart.

Chow YW, Lim BB, Hooi LS.

Med J Malaysia. 2007 Mar;62(1):27-32.

45.

Dialysis in Malaysia.

Hooi LS.

Med J Malaysia. 2006 Dec;61(5):513-5. No abstract available.

46.

A randomized, multicenter, open-label trial to determine peritonitis rate, product defect, and technique survival between ANDY-Disc and UltraBag in patients on CAPD.

Wong HS, Ong LM, Lim TO, Hooi LS, Morad Z, Ghazalli R, Shaariah W, Lim YN, Ahmad G, Goh BL, Liaw L, Pee S, Lee ML.

Am J Kidney Dis. 2006 Sep;48(3):464-72.

PMID:
16931220
47.

Germline transmission of genetically modified primordial germ cells.

van de Lavoir MC, Diamond JH, Leighton PA, Mather-Love C, Heyer BS, Bradshaw R, Kerchner A, Hooi LT, Gessaro TM, Swanberg SE, Delany ME, Etches RJ.

Nature. 2006 Jun 8;441(7094):766-9.

PMID:
16760981
48.

Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis.

Ong LM, Hooi LS, Lim TO, Goh BL, Ahmad G, Ghazalli R, Teo SM, Wong HS, Tan SY, Shaariah W, Tan CC, Morad Z.

Nephrology (Carlton). 2005 Oct;10(5):504-10.

PMID:
16221103
49.
50.

Validity and reliability of the SF-36: the Malaysian context.

Sararaks S, Azman AB, Low LL, Rugayah B, Aziah AM, Hooi LN, Abdul Razak M, Norhaya MR, Lim KB, Azian AA, Geeta S.

Med J Malaysia. 2005 Jun;60(2):163-79.

Supplemental Content

Support Center